• 한국발생생물학회지:발생과생식
• /
• 제23권2호
• /
• pp.79-92
• /
• 2019

Humanized mice, containing engrafted human cells and tissues, are emerging as an important in vivo platform for studying human diseases. Since the development of Nod scid gamma (NSG) mice bearing mutations in the IL-2 receptor gamma chain, many investigators have used NSG mice engrafted with human hematopoietic stem cells (HSCs) to generate functional human immune systems in vivo, results in high efficacy of human cell engraftment. The development of NSG mice has allowed significant advances to be made in studies on several human diseases, including cancer and graft-versus-host-disease (GVHD), and in regenerative medicine. Based on the human HSC transplantation, organ transplantation including thymus and liver in the renal capsule has been performed. Also, immune reconstruction of cells, of the lymphoid as well as myeloid lineages, has been partly accomplished. However, crosstalk between pluripotent stem cell derived therapeutic cells with human leukocyte antigen (HLA) mis/matched types and immune CD3 T cells have not been fully addressed. To overcome this hurdle, human major histocompatibility complex (MHC) molecules, not mouse MHC molecules, are required to generate functional T cells in a humanized mouse model. Here, we briefly summarize characteristics of the humanized mouse model, focusing on development of CD3 T cells with MHC molecules. We also highlight the necessity of the humanized mouse model for the treatment of various human diseases.

• 대한생식의학회:학술대회논문집
• /
• 대한불임학회 2003년도 제44차 춘계학술대회
• /
• pp.59-64
• /
• 2003

• 대한자기공명의과학회:학술대회논문집
• /
• 대한자기공명의과학회.한국자기공명학회 2005년도 공동학술대회
• /
• pp.14-14
• /
• 2005

• Biomolecules & Therapeutics
• /
• 제27권1호
• /
• pp.78-84
• /
• 2019

Cell therapeutic agents for treating degenerative brain diseases using neural stem cells are actively being developed. However, few systems have been developed to monitor in real time whether the transplanted neural stem cells are actually differentiated into neurons. Therefore, it is necessary to develop a technology capable of specifically monitoring neuronal differentiation in vivo. In this study, we established a system that expresses cell membrane-targeting red fluorescent protein under control of the Synapsin promoter in order to specifically monitor differentiation from neural stem cells into neurons. In order to overcome the weak expression level of the tissue-specific promoter system, the partial 5' UTR sequence of Creb was added for efficient expression of the cell surface-specific antigen. This system was able to track functional neuronal differentiation of neural stem cells transplanted in vivo, which will help improve stem cell therapies.

• Interdisciplinary Bio Central
• /
• 제2권2호
• /
• pp.3.1-3.4
• /
• 2010

In the present research, we assessed the utility of the structural information of drugs for predicting human in vivo intrinsic clearance from in vitro intrinsic clearance data obtained by human hepatic microsome experiment. To compare with the observed intrinsic clearance, human intrinsic clearance values for 51 drugs were estimated by the classical methods using in vivo-in vitro scale-up and by the new methods using the in vitro experimental data and selected molecular descriptors of drugs by the forward selection technique together. The results showed that taking consideration of molecular descriptors into prediction from in vitro experimental data could improve the prediction accuracy. The in vitro experiment is very useful when the data can estimate in vivo data accurately since it can reduce the cost of drug development. Improvement of prediction accuracy in the present approach can enhance the utility of in vitro data.

• 한국수정란이식학회지
• /
• 제12권1호
• /
• pp.57-66
• /
• 1997

This study was carried out to establish an effective and practical system for commercialization of embryo production techniques by analyzing several factors influencing in vivo embryo production on days and seasons of flushing in Korean native cattle. In vivo embryos were flushed 226 times from 128 donors. The results obtained for the factors influencing in vivo embryo production on days and seasons of flushing were as follows :1.The percentages of fertilized, transferable and freezable embryos by seasons were significantly different in both FSR-P and SUPER-OV(P<0.01). The percentages of them were highest in sunrrner with FS H-P and highest in autumn with SUPER -OV.2. The production of transferable and freezable embryos by flushing days was highest in 8 days with FSH-P, and there was no difference between 7 and 8 days for SUP ER-OV. 3. The failure rates of recovery were 17.0% in SUPER-OV and 21.2% in FSH-P, respectively. The donors superovulated but failed recovery were 8.5% in SUPER-OV and 12.9% in FSH-P, respectively. Nonsuperovulated donors was 8.4% and donors giving less than 2 eggs at recovery was 8.4% in both FSH -P and SUPER-OV 4. The donors returned to normal estrus after superovulation were 34.1% after 1 cycle,39.4% after 2 cycles, and 16.7% after 3 cycles by FSH-P, respectively. For SUPER-OV, they were 55.3, 33.0 and 9.6%, respectively. Generally, normal estrus after the treatment of superovulation was earlier and the occurrence of ovarian cyst was also lower in SUP ER-OV than in FSH-P.5.The percentages of blastocyst in embryos flushed at 7~8 days after estrus were 21. 9% and 54.3% in FSH -P and SUPER-OV, respectively. The development of embryos was faster in SUPER-OV than in FSH-P.(Key words : in vivo embryo, flushing days, superovulation, FSH-P, SUPER-OV)

• Journal of Communications and Networks
• /
• 제14권3호
• /
• pp.296-309
• /
• 2012

In existing middleware for body sensor networks, energy limitations, hardware heterogeneity, increases in node temperature, and the absence of software reusability are major problems. In this paper, we propose an event-based grid middleware component that solves these problems using distributed resources in in vivo sensor nodes. In our multi-hop communication, we use a lightweight rendezvous routing algorithm in a publish/subscribe system of event-based communication. To facilitate software reuse and application development, a modified open services gateway initiative has been implemented in our middleware architecture. We evaluated our grid middleware in a cancer treatment scenario with combined hyperthermia, chemotherapy, and radiotherapy procedures, using in vivo sensors.

• Archives of Pharmacal Research
• /
• 제27권11호
• /
• pp.1168-1176
• /
• 2004

Exposure to stress is known to precipitate or exacerbate many reproductive dysfunctions such as dysmenorrhea and infertility. Abnormalities of the reproductive system, as shown by reduced ovulation, fertilization and early embryonic development, are frequently seen in dysmenorrhea and infertility. It has been generally accepted that Gamisoyosan (GSS) is a useful prescription for treating insomnia, dysmenorrhea and infertility induced by a stress. Also GSS has been used traditionally to improve systemic circulation and biological energy production. Based on these, this study investigates whether GSS improved ovarian dysfunction caused by stress in mice. Mice were subjected to stress by electric shock on the foot for 30 min daily for a week and treated with GSS at 500 / body weight per day for one week. Thereafter, changes body weight, adrenal weight, ovulation rate, in vitro and in vivo fertilization, embryonic development and estradiol concentrations were measured. GSS markedly increased the body weight of mice with stress, but not normal mice. The administration of GSS caused a reduction in adrenal weight in stressed mice. GSS also had significant positive effects on ovulation rate, estradiol production, in vivo and in vitro fertilization rates and embryonic development. These results indicate that GSS can improve the reproductive dysfunctions caused by stress, and these may production biological energy.

• Clinical and Experimental Reproductive Medicine
• /
• 제24권2호
• /
• pp.261-265
• /
• 1997

본 연구는 EGF가 체외수정 및 체외배양에 의해 생산된 생쥐배의 체내 발달에 미치는 영향을 조사하고자 실시하였다. 본 실험에 사용된 난자는 체외수정 후 얻어진 2-세포기배를 EGF 첨가유무에 따라 배양 (5-6 embryos/25${\mu}l$/drop)하여 얻어진 4일령의 배반포기배로서, 각 처리군의 배반포기배는 가임신 3일된 대리모의 자궁내에 이식되어졌다. 그 결과를 요약하면 다음과 같다. 1,2-세포기배를 EGF의 첨가유무에 따라 배양하여 배반포기배로의 발달율과 세포수를 조사하였던 바, 처리군간의 유의한 차이는 나타나지 않았다. 2. 하지만, 각 처리군에서 회수된 배반포기배의 체내 발달을 조사하였던 바, 총 수태율의 결과에 있어서는 대조군과 EGF 처리군 각각 64.4%와 69.8%로서 두 군간에 유의한 차이를 나타내지 않았지만, 정상태아 발생율에 있어서는 EGF 처리군 (51.2%)이 대조군 (31.1%)보다 매우 높게 나타냈다. 따라서, 비록 EGF 처리군이 대조군과 비교하여 볼 때 체외수정 및 체외배양에 의해 생산된 난자의 유의한 발달은 나타내지 않았지만 난자의 질적인 향상을 통해서 체내발달을 증진시킬 수 있을 것으로 사료된다.

• Preventive Nutrition and Food Science
• /
• 제21권3호
• /
• pp.197-201
• /
• 2016

Helicobacter pylori infection is associated with an increased risk of developing upper gastrointestinal tract diseases. However, treatment failure is a major cause of concern mainly due to possible recurrence of infection, the side effects, and resistance to antibiotics. The aim of this study was to investigate the activities of Centella asiatica leaf extract (CAE) against H. pylori both in vitro and in vivo. The minimum inhibitory concentrations (MICs) against 55 clinically isolated strains of H. pylori were tested using an agar dilution method. The MICs of CAE ranged from 0.125 mg/mL to 8 mg/mL, effectiveness in inhibiting H. pylori growth was 2 mg/mL. The anti-H. pylori effects of CAE in vivo were also examined in H. pylori-infected C57BL/6 mice. CAE was orally administrated once daily for 3 weeks at doses of 50 mg/kg and 250 mg/kg. CAE at the 50 mg/kg dose significantly reduced H. pylori colonization in mice gastric mucosa. Our study provides novel insights into the therapeutic effects of CAE against H. pylori infection, and it suggests that CAE may be useful as an alternative therapy.